The oral microbiome and inflammation in mild cognitive impairment

Irene Yang1, Robert Adam Arthur2, Liping Zhao3

  • 1Emory University, Nell Hodgson Woodruff School of Nursing, 1520 Clifton Road NE Room 424, Atlanta, GA 30322, United States of America.

Experimental Gerontology
|February 8, 2021
PubMed

Insights

This study found specific oral bacteria linked to mild cognitive impairment (MCI), a precursor to Alzheimer's disease. These findings suggest potential new diagnostic tools and prevention strategies for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Alzheimer's disease (AD) pathogenesis involves inflammation and immune responses.
  • Poor oral health, including periodontal disease and dental caries, is linked to increased Alzheimer's disease risk.
  • Mild cognitive impairment (MCI) is a recognized precursor stage to Alzheimer's disease.

Purpose of the Study:

  • To investigate the oral microbiome composition in individuals with MCI compared to cognitively normal controls.
  • To explore the relationship between oral microbiome profiles, MCI diagnostic markers, and systemic inflammation.
  • To identify potential microbial and inflammatory biomarkers for early detection of MCI.

Main Methods:

  • 16S rRNA sequencing was employed to analyze the oral microbiome.
  • The study included 68 older adults, categorized as MCI or cognitively normal.
  • Cerebrospinal fluid (CSF) and blood samples were analyzed for inflammatory mediators.

Main Results:

  • Two oral bacterial taxa, Pasteurellacae and Lautropia mirabilis, were found to be differentially abundant in the MCI group.
  • No significant differences in systemic inflammatory markers were observed between MCI and control groups.
  • Five CSF inflammatory mediators showed significant differences and associations with MCI status.

Conclusions:

  • Specific alterations in the oral microbiome are associated with mild cognitive impairment.
  • Cerebrospinal fluid inflammatory mediators, not systemic markers, correlate with MCI.
  • Further research into oral microbiome and CNS inflammation may yield novel diagnostic and therapeutic targets for Alzheimer's disease prevention and mitigation.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
611
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
653
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
503